Skip to content

Cryoanalgesia Aplication Time Optimization During Nuss Procedure

The Optimization of the Intercostal Nerves Cryoablation Aplication Time During Nuss Procedure

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05831137
Enrollment
20
Registered
2023-04-26
Start date
2023-03-31
Completion date
2023-07-10
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Excavatum, Pectus, Funnel Chest

Keywords

nuss procedure, cryoanalgesia

Brief summary

This study compared standard therapy (multimodal analgesia with 2 minutes cryoanalgesia) versus a novel approach (multimodal analgesia with 1 minute cryoanalgesia) in subject undergoing minimal invasive modyfied Nuss procedure with thoracoscopy.

Detailed description

Funnel chest deformation may be a great challenge for therapeutic teams due to severe pain in the postoperative period as well as chronic pain. 2 minutes per one intercostal nerve aplication cryoanalgesia as a part of multimodal analgesia is a standard protocol in many countries. This Prospective Non-Randomized Study is a single institution pilot study designed to compare standard therapy (control side: multimodal analgesia with 2 minutes cryoanalgesia) versus a novel approach (multimodal analgesia with 1 minute cryoanalgesia) in each patient to address the need for better management of acute and long-term pain in the pediatric population diagnosed with funnel-chest and treated using the modyfied Nuss method. All of the patients will receive a standard care according to Polish guidelines: multimodal analgesia with regional analgesia (bilateral erector spine plane block) with cryoanalgesia. The right intercostal nerves will be treated with 2 minutes cryoanalgesia (control side). The left side of the chest (left intercostal nerves) will be treated with 1 minute cryoanalgesia (intervention side). The intraoperative cryoanalgesia will be performed using the Cryo-S Painless device (Metrum - Cryoflex Polska Limited). The study will assess the effectiveness of shorter aplication duration time of cryoanalgesia as a method of acute and long-term pain control and safety of the method. Specific Aim: To determine if, compared with current 2 minutes cryoanalgesia protocol, 1 minute aplication time of cryoanalgesia is effective at the same level when consider pain control and postoperative functioning in each patient. The results were compared in terms of demographics, right versus left side of the chest pain levels, quality and length of rehabilitation and patient satisfaction using the Quality of Life by modyfied Nuss questionnaire.

Interventions

PROCEDUREshorter cryoanalgesia

duration time of cryoanalgesia

Sponsors

Pomeranian Medical University Szczecin
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Intervention model description

In each patient one side of the chest will be treated by standard metod and the second side will be treated with the novel method.

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing pectus excavatum repair with modyfied minimal invasive thoracoscopic Nuss technique * informed concent signed for cryolesia

Exclusion criteria

* age 9 years or below * refuse to receive cryoanalgesia or regional anaesthesia as a primary pain relief

Design outcomes

Primary

MeasureTime frameDescription
The worse pain occurrence during first 24 hours after operation.up to 24 hours after operationnumeric pain score, range from 0 to 10

Secondary

MeasureTime frameDescription
thoracic hypoaesthesia occurrenceup to 24 hours after operationcold test assessment (yes / no)
residual wound or chest pain occurrencepostoperative months 1,3the chest or wound chronic pain occurrence
duration of hospitalizationestimated 4 daysthe lengh of the time in days spent in the hospital

Countries

Poland

Contacts

Primary ContactJowita Biernawska, MD PhD
lisienko@wp.pl+48501337073
Backup ContactSlawomir Zacha, MD PhD
sekozacha@gmail.com+48513100813

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026